UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

BRCA1 Deficiency Upregulates NNMT, Which Reprograms Metabolism and Sensitizes Ovarian Cancer Cells to Mitochondrial Metabolic Targeting Agents

Cancer research (Chicago, Ill.), 2019-12, Vol.79 (23), p.5920-5929

2019

Volltextzugriff (PDF)

In vitro and in vivo antitumor effects of the dual insulin-like growth factor-I/insulin receptor inhibitor, BMS-554417

Cancer research (Chicago, Ill.), 2006-01, Vol.66 (1), p.362-371

2006

Volltextzugriff (PDF)

APOBEC3B upregulation and genomic mutation patterns in serous ovarian carcinoma

Cancer research (Chicago, Ill.), 2013-12, Vol.73 (24), p.7222-7231

2013

Volltextzugriff (PDF)

A Phase I trial of the farnesyl transferase inhibitor SCH66336: evidence for biological and clinical activity

Cancer research (Chicago, Ill.), 2000-04, Vol.60 (7), p.1871

2000

Volltextzugriff (PDF)

Endothelial p-selectin as a target of heparin action in experimental melanoma lung metastasis

Cancer research (Chicago, Ill.), 2004-04, Vol.64 (8), p.2743-2750

2004

Volltextzugriff (PDF)

Cell-type-specific responses to chemotherapeutics in breast cancer

Cancer research (Chicago, Ill.), 2004-06, Vol.64 (12), p.4218-4226

2004

Volltextzugriff (PDF)

Abstract A19: Discovery and characterization of selective and nonselective inhibitors of ErbB4 signaling: Putative targeted melanoma therapeutics

Cancer research (Chicago, Ill.), 2020-10, Vol.80 (19_Supplement), p.A19-A19

2020

Volltextzugriff (PDF)

Flavopiridol binds to duplex DNA

Cancer research (Chicago, Ill.), 2000-05, Vol.60 (9), p.2419-2428

2000

Volltextzugriff (PDF)

Loss of expression of a new member of the DNAJ protein family confers resistance to chemotherapeutic agents used in the treatment of ovarian cancer

Cancer research (Chicago, Ill.), 2001-05, Vol.61 (10), p.4258-4265

2001

Volltextzugriff (PDF)

The Estrogen receptor CpG island is methylated in most hematopoietic neoplasms

Cancer research (Chicago, Ill.), 1996-03, Vol.56 (5), p.973-977

1996

Volltextzugriff (PDF)

Bile acids inhibit Mcl-1 protein turnover via an epidermal growth factor receptor/Raf-1-dependent mechanism

Cancer research (Chicago, Ill.), 2002-11, Vol.62 (22), p.6500-6505

2002

Volltextzugriff (PDF)

DNA-dependent protein kinase is not required for accumulation of p53 or cell cycle arrest after DNA damage

Cancer research (Chicago, Ill.), 1997, Vol.57 (1), p.68-74

1997

Volltextzugriff (PDF)

Abstract P5-08-01: Pilot study of a patient-reported outcome (PRO) measurement strategy to determine impact of screening for minimal residual disease (MRD) in high-risk breast cancer survivors

Cancer research (Chicago, Ill.), 2023-03, Vol.83 (5_Supplement), p.P5-P5-08-01

2023

Volltextzugriff (PDF)

Defective G2 checkpoint function in cells from individuals with familial cancer syndromes

Cancer research (Chicago, Ill.), 1995-04, Vol.55 (8), p.1763-1773

1995

Volltextzugriff (PDF)

S5-4: pCR as a Surrogate in HER2−Positive Patients Treated with Trastuzumab

Cancer research (Chicago, Ill.), 2011-12, Vol.71 (24_Supplement), p.S5-S5-4

2011

Volltextzugriff (PDF)

S3-2: Neoadjuvant Chemotherapy Adapted by Interim Response Improves Overall Survival of Primary Breast Cancer Patients – Results of the GeparTrio Trial

Cancer research (Chicago, Ill.), 2011-12, Vol.71 (24_Supplement), p.S3-S3-2

2011

Volltextzugriff (PDF)

PD07-05: Local Recurrence Risk in 6377 Patients with Early Breast Cancer Receiving Neoadjuvant Anthracycline-Taxane +/− Trastuzumab Containing Chemotherapy

Cancer research (Chicago, Ill.), 2011-12, Vol.71 (24_Supplement), p.PD07-05-PD07-05

2011

Volltextzugriff (PDF)

P2-12-26: Impact of the Recurrence Score on Adjuvant Decision-Making in ER-Positive Early Breast Cancer – Results of a Large Prospective Multicentre Decision Impact Study in Node Negative and Node Positive Disease

Cancer research (Chicago, Ill.), 2011-12, Vol.71 (24_Supplement), p.P2-P2-12-26

2011

Volltextzugriff (PDF)

Abstract P6-07-05: Prognosis of 368 women with primary breast cancer during pregnancy: results from an international collaborative trial

Cancer research (Chicago, Ill.), 2012-12, Vol.72 (24_Supplement), p.P6-P6-07-05

2012

Volltextzugriff (PDF)

Validated 3 Gene Signature Predicts Response to Neo-Adjuvant Chemotherapy in Luminal Breast Cancer – Results from GeparTrio and GeparQuattro

Cancer research (Chicago, Ill.), 2009-12, Vol.69 (24_Supplement), p.2132-2132

2009

Volltextzugriff (PDF)

P1-06-26: The EndoPredict Score Is a Response Predictor for Neoadjuvant Chemotherapy in ER-Positive, HER2−Negative Breast Cancer

Cancer research (Chicago, Ill.), 2011-12, Vol.71 (24_Supplement), p.P1-P1-06-26

2011

Volltextzugriff (PDF)

Abstract S3-1: Lapatinib vs Trastuzumab in Combination with Neoadjuvant Anthracycline-Taxane-Based Chemotherapy: Primary Efficacy Endpoint Analysis of the GEPARQUINTO STUDY (GBG 44)

Cancer research (Chicago, Ill.), 2010-12, Vol.70 (24_Supplement), p.S3-S3-1

2010

Volltextzugriff (PDF)

Drug efflux by breast cancer resistance protein (BCRP) is a mechanism of resistance to the insulin-like growth factor receptor/insulin receptor inhibitor, BMS-536924

Cancer research (Chicago, Ill.), 2009-01, Vol.69 (2_Supplement), p.2149

2009

Volltextzugriff (PDF)

Defective postreplication repair in xeroderma pigmentosum variant fibroblasts

Cancer research (Chicago, Ill.), 1990-05, Vol.50 (9), p.2593-2598

1990

Volltextzugriff (PDF)

Role of postreplication repair in transformation of human fibroblasts to anchorage independence

Cancer research (Chicago, Ill.), 1991-06, Vol.51 (11), p.2960-2964

1991

Volltextzugriff (PDF)

1 – 25 von 26

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieCancer Research

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(26)

Publikationsform

Artikel
(26)

Sprache

Englisch
(26)

Erscheinungsjahr

n.n

Kollektion

Menü

Weitere Dienste

Einstellungen

BRCA1 Deficiency Upregulates NNMT, Which Reprograms Metabolism and Sensitizes Ovarian Cancer Cells to Mitochondrial Metabolic Targeting Agents

In vitro and in vivo antitumor effects of the dual insulin-like growth factor-I/insulin receptor inhibitor, BMS-554417

APOBEC3B upregulation and genomic mutation patterns in serous ovarian carcinoma

A Phase I trial of the farnesyl transferase inhibitor SCH66336: evidence for biological and clinical activity

Endothelial p-selectin as a target of heparin action in experimental melanoma lung metastasis

Cell-type-specific responses to chemotherapeutics in breast cancer

Abstract A19: Discovery and characterization of selective and nonselective inhibitors of ErbB4 signaling: Putative targeted melanoma therapeutics

Flavopiridol binds to duplex DNA

Loss of expression of a new member of the DNAJ protein family confers resistance to chemotherapeutic agents used in the treatment of ovarian cancer

The Estrogen receptor CpG island is methylated in most hematopoietic neoplasms

Bile acids inhibit Mcl-1 protein turnover via an epidermal growth factor receptor/Raf-1-dependent mechanism

DNA-dependent protein kinase is not required for accumulation of p53 or cell cycle arrest after DNA damage

Abstract P5-08-01: Pilot study of a patient-reported outcome (PRO) measurement strategy to determine impact of screening for minimal residual disease (MRD) in high-risk breast cancer survivors

Defective G2 checkpoint function in cells from individuals with familial cancer syndromes

S5-4: pCR as a Surrogate in HER2−Positive Patients Treated with Trastuzumab

S3-2: Neoadjuvant Chemotherapy Adapted by Interim Response Improves Overall Survival of Primary Breast Cancer Patients – Results of the GeparTrio Trial

PD07-05: Local Recurrence Risk in 6377 Patients with Early Breast Cancer Receiving Neoadjuvant Anthracycline-Taxane +/− Trastuzumab Containing Chemotherapy

P2-12-26: Impact of the Recurrence Score on Adjuvant Decision-Making in ER-Positive Early Breast Cancer – Results of a Large Prospective Multicentre Decision Impact Study in Node Negative and Node Positive Disease

Abstract P6-07-05: Prognosis of 368 women with primary breast cancer during pregnancy: results from an international collaborative trial

Validated 3 Gene Signature Predicts Response to Neo-Adjuvant Chemotherapy in Luminal Breast Cancer – Results from GeparTrio and GeparQuattro

P1-06-26: The EndoPredict Score Is a Response Predictor for Neoadjuvant Chemotherapy in ER-Positive, HER2−Negative Breast Cancer

Abstract S3-1: Lapatinib vs Trastuzumab in Combination with Neoadjuvant Anthracycline-Taxane-Based Chemotherapy: Primary Efficacy Endpoint Analysis of the GEPARQUINTO STUDY (GBG 44)

Drug efflux by breast cancer resistance protein (BCRP) is a mechanism of resistance to the insulin-like growth factor receptor/insulin receptor inhibitor, BMS-536924

Defective postreplication repair in xeroderma pigmentosum variant fibroblasts

Role of postreplication repair in transformation of human fibroblasts to anchorage independence

Aktive Filter

Suchergebnisse filtern